Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy.


Journal

Familial cancer
ISSN: 1573-7292
Titre abrégé: Fam Cancer
Pays: Netherlands
ID NLM: 100898211

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 9 6 2018
medline: 16 7 2019
entrez: 9 6 2018
Statut: ppublish

Résumé

This cross-sectional study aimed to investigate the effect of premenopausal risk reducing salpingo-oophorectomy (RRSO) on the cholesterol profile of women at increased ovarian cancer risk and to assess possible effects of age at and time since RRSO. We included 207 women who underwent RRSO before menopausal age (52 years) attending the family cancer clinic of an academic hospital and 828 age-matched women from a general population cohort (PREVEND). Participants filled out a questionnaire on socio-demographic characteristics, lifestyle and medical history, had anthropometric measurements and provided blood samples for assessment of serum levels of total cholesterol, HDL-cholesterol and non-HDL-cholesterol. The correlation between RRSO and cholesterol profile was assessed with logistic regression. Furthermore, subgroup analyses were performed to explore a possible effect of age at and time since RRSO. At a median time of 5.9 years (range 2.3-25.2) after surgery, RRSO was associated with low (< 60 mg/dl) HDL-cholesterol (OR 9.74, 95% CI 5.19-18.26) and high (≥ 160 mg/dl) non-HDL-cholesterol (OR 1.85, 95% CI 1.21-2.82) when adjusting for body mass index, hormone therapy, participation on sports and previous chemotherapy. The observed association was not dependent on age or time since RRSO. The RRSO group had less smokers (19.3 vs. 25.8%) and more participation on sports (45.4 vs. 22.0%). Our results suggest that RRSO is associated with a more atherogenic cholesterol profile, despite a lower prevalence of smoking and higher prevalence of participation on sports as compared to controls. This observation can be useful for physicians involved in the counselling and follow-up of women having RRSO.

Identifiants

pubmed: 29881922
doi: 10.1007/s10689-018-0091-5
pii: 10.1007/s10689-018-0091-5
pmc: PMC6323069
doi:

Substances chimiques

BRCA1 Protein 0
BRCA1 protein, human 0
BRCA2 Protein 0
BRCA2 protein, human 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-27

Références

Fertil Steril. 2016 Dec;106(7):1580-1587
pubmed: 27793381
JAMA. 2009 Nov 11;302(18):1993-2000
pubmed: 19903920
Fam Cancer. 2012 Mar;11(1):69-75
pubmed: 21898151
J Clin Endocrinol Metab. 2008 Jun;93(6):2129-34
pubmed: 18334591
Curr Cardiol Rep. 2015 Jul;17(7):609
pubmed: 26026998
Cancer Treat Rev. 2000 Dec;26(6):429-47
pubmed: 11139373
J Natl Cancer Inst. 2009 Jan 21;101(2):80-7
pubmed: 19141781
Eur Heart J. 2003 Jun;24(11):987-1003
pubmed: 12788299
Maturitas. 2006 Jan 20;53(2):226-33
pubmed: 15955642
J Am Coll Cardiol. 2009 Dec 15;54(25):2366-73
pubmed: 20082925
Maturitas. 2015 May;81(1):62-8
pubmed: 25804951
Semin Reprod Med. 2010 Sep;28(5):426-34
pubmed: 20865657
N Engl J Med. 1987 Apr 30;316(18):1105-10
pubmed: 3574358
Menopause. 2006 Mar-Apr;13(2):265-79
pubmed: 16645540
J Clin Endocrinol Metab. 2003 Jun;88(6):2404-11
pubmed: 12788835
PLoS One. 2017 Jan 6;12(1):e0169673
pubmed: 28060958
Eur Heart J. 2016 Jul 01;37(25):1944-58
pubmed: 27122601
Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
Circulation. 1996 Jul 1;94(1):61-6
pubmed: 8964119
J Clin Endocrinol Metab. 2007 Aug;92(8):3040-3
pubmed: 17519304
Eur Heart J. 2000 Dec;21(23):1922-7
pubmed: 11071797
N Engl J Med. 2002 May 23;346(21):1616-22
pubmed: 12023993
Eur J Cancer. 2015 Feb;51(3):400-8
pubmed: 25532426
Obes Rev. 2012 Apr;13(4):368-80
pubmed: 22133030
Menopause. 2009 Jan-Feb;16(1):15-23
pubmed: 19034050
Int J Gynecol Cancer. 2010 Feb;20(2):233-9
pubmed: 20169665
Menopause. 2007 May-Jun;14(3 Pt 2):562-6
pubmed: 17476145
Gynecol Oncol. 2008 Jun;109(3):377-83
pubmed: 18407340
Eur J Cancer. 2009 Jan;45(1):82-9
pubmed: 19008092
J Am Coll Cardiol. 2009 Jan 27;53(4):316-22
pubmed: 19161879
JAMA Intern Med. 2016 Jul 1;176(7):1005-6
pubmed: 27119719
Curr Opin Lipidol. 2013 Jun;24(3):214-20
pubmed: 23594711

Auteurs

Natalia Teixeira (N)

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands. n.teixeira@umcg.nl.
Department of Gynaecologic Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. n.teixeira@umcg.nl.

Marian J Mourits (MJ)

Department of Gynaecologic Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Jan C Oosterwijk (JC)

Department of Clinical Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Ingrid E Fakkert (IE)

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.
Department of Gynaecologic Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Anthony R Absalom (AR)

Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Stephan J L Bakker (SJL)

Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Peter van der Meer (P)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Geertruida H de Bock (GH)

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH